Dobrovolsky Vasily N, Shaddock Joseph G, Mittelstaedt Roberta A, Miura Daishiro, Heflich Robert H
Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
Strategic Planning Division, Pharmaceutical Business Planning Department, Teijin Pharma Limited, Tokyo, Japan.
Methods Mol Biol. 2019;2031:59-75. doi: 10.1007/978-1-4939-9646-9_3.
Assays for in vivo mutation are used to identify genotoxic hazards and phenotypes prone to genomic instability and cancer. The hypoxanthine guanine phosphoribosyl transferase (Hprt) gene and the phosphatidyl inositol glycan, class A (Pig-a) gene are endogenous X-linked genes that can be used as reporters of mutation in peripheral blood lymphocytes from most mammals. Here we describe methodology for measuring Hprt and Pig-a mutation in rat T-lymphocytes. The identification and selective expansion of mutant lymphocytes is based upon the phenotypic properties of Hprt- and Pig-a-deficient cells, that is, resistance to the purine analog, 6-thioguanine, or to the bacterial toxin, proaerolysin. Expanded mutants can be further analyzed by sequencing cDNA from the target transcripts for identification of small sequence alterations and by multiplex PCR analysis of genomic DNA for the detection of deletions.
体内突变检测用于识别遗传毒性危害以及易于发生基因组不稳定和癌症的表型。次黄嘌呤鸟嘌呤磷酸核糖转移酶(Hprt)基因和磷脂酰肌醇聚糖A类(Pig-a)基因是内源性X连锁基因,可作为大多数哺乳动物外周血淋巴细胞中突变的报告基因。在此,我们描述了测量大鼠T淋巴细胞中Hprt和Pig-a突变的方法。突变淋巴细胞的鉴定和选择性扩增基于Hprt和Pig-a缺陷细胞的表型特性,即对嘌呤类似物6-硫鸟嘌呤或细菌毒素前气溶素的抗性。扩增后的突变体可以通过对靶转录本的cDNA进行测序以鉴定小的序列改变,并通过对基因组DNA进行多重PCR分析以检测缺失,从而进行进一步分析。